Merck repeats: We didn&#39;t know of Vioxx threat
237814
Merck (MRK) officials on Wednesday called a press conference to reiterate that they did not believe until last month that Vioxx raised users&#39; risk of heart attacks or strokes.
70993
BIRMINGHAM, Alabama  - Merck & Co. scored its second swift victory this week in a Vioxx product liability trial when an Alabama jury found on Friday it did not hide health risks associated with its withdrawn arthritis drug or knowingly market a faulty product.
26730
Prescription-drug recalls aren&#39;t common, and they&#39;re almost always controversial. Now that Merck (MRK ) is voluntarily withdrawing its Vioxx pain medication around the world, due to a heightened risk of cardiovascular
38641
An Oklahoma lawsuit filed on Thursday charges that Merck &amp; Co. misled patients about the safety of its arthritis drug. The case may signal many more such lawsuits against the drugmaker
151416
Merck &amp; Co. said US securities regulators and the Justice Department opened inquiries concerning the painkiller Vioxx, withdrawn Sept.
332433
Merck&#39;s (MRK :NYSE - news - research) decision to withdraw its popular arthritis drug Vioxx from the market in late September has raised questions about the process leading up to its regulatory approval in 1999 as well as the importance of subsequent
721591
Merck &amp; Co., Inc., knew of problems with its blockbuster painkiller Vioxx long before the drug was pulled from the market in September due to newer studies that linked the medication to an increased risk of heart attack and stroke, the Wall Street Journal
29190
NEW YORK - The withdrawal of the arthritis drug Vioxx two weeks ago was a disaster for Merck. But it also put rival Pfizer in a fix.
79247
Merck &amp; Co., which withdrew the Vioxx painkiller last month because of a heart risk, said yesterday that US regulators have asked for more safety data before they will approve the medicine&#39;s successor, Arcoxia.
644655
The Food and Drug Administration ignored danger signals from its own scientists about Merck and Co. Inc.'s Vioxx painkiller, Sen. Charles Grassley told a hearing Thursday into the drug's withdrawal in September.
292468
Responding to continuing criticism that it mishandled internal warnings that the painkiller Vioxx had deadly side effects and that antidepressants were
496967
The House Energy and Commerce Committee is investigating how Vioxx was approved and then taken off the market. It has written to Lester Crawford, FDA, and Ray Gilmartin, CEO of Merck, requesting documents about Vioxx.
695199
Less than three months after Merck withdrew its pain-killer Vioxx from the US after concerns about side-effects, questions over Pfizer&#39;s competitor products are provoking
646131
U.S. drugs giant Merck & Co Inc. should have pulled its Vioxx painkiller from the market four years ago because data showing it raised the risk of heart attacks has existed since 2000, Swiss scientists said on Friday.
667
The Food and Drug Administration insists that until pharmaceutical giant Merck presented new information this week, there was not enough evidence to pull the arthritis drug Vioxx off the market.
81161
Drug giant Merck pulled its painkiller Vioxx because it increased the risk of heart attacks and strokes. Now the company may face thousands of lawsuits.
711195
On Thursday, Merck &amp; Co Inc. recalled its popular arthritis pain medication Vioxx from the market making one of the biggest drug withdrawals in the US history.